Home » Food & Beverage » Prebiotics Market

Global Prebiotics Market By Product Segment (Fructo-Oligosaccharides, Insulin, Pyrodextrins, Galacto-Oligosaccharides, Soya Oligosaccharides, Lactulose, Isomalto-Oligosaccharides, Others); By Disease Type Segment (Diabetes, Infections, Cardiovascular Diseases, Osteoporosis, IBD, Immunomodulation, Others); By Demography Segment (Pediatric, Adult, Geriatric); By Distribution Channel Segment (Hypermarkets/Supermarkets, Pharmacies and Drug Stores, Specialty Stores, Online Sales, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: Prebiotics Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-10-26
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: Prebiotics Market

Summary
Table Of Content
Request Free Sample

Market Overview:

The Global Prebiotics Market size was valued at USD 5,400.00 million in 2018 to USD 6,861.99 million in 2024 and is anticipated to reach USD 12,304.06 million by 2032, at a CAGR of 7.65% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Prebiotics Market Size 2024	USD 6,861.99 million
Prebiotics Market, CAGR	7.65%
Prebiotics Market Size 2032	USD 12,304.06 million

The key drivers of this market include growing awareness about gut health, increasing cases of lifestyle-related digestive disorders, and rising preference for natural and clean-label ingredients. Expanding applications of prebiotics in animal feed, pharmaceuticals, and personal care further contribute to growth. Continuous product innovation, including inulin, galacto-oligosaccharides, and fructo-oligosaccharides, strengthens market competitiveness and diversification.

Regionally, Europe dominates the Global Prebiotics Market due to strong regulatory support for functional foods and high consumer adoption of wellness-oriented products. North America follows closely, supported by expanding clinical research and fortified food launches. Asia-Pacific is expected to witness the fastest growth, driven by rising disposable incomes, growing health consciousness, and an expanding food manufacturing base in China, India, and Japan. This regional shift highlights the global transition toward preventive health and nutrition-focused consumption patterns.

Prebiotics Market size

Market Insights:

The Global Prebiotics Market was valued at USD 5,400.00 million in 2018, reached USD 6,861.99 million in 2024, and is expected to attain USD 12,304.06 million by 2032, growing at a CAGR of 7.65% during the forecast period.
Europe holds 30% of the global share, leading due to strong regulatory backing for functional foods and high consumer adoption of wellness products. North America follows with 35% share, driven by innovation in dietary supplements and fortified foods.
Asia-Pacific holds 25% share and represents the fastest-growing region, supported by rising disposable incomes, expanding food manufacturing, and growing health awareness in China, India, and Japan.
By product, fructo-oligosaccharides and inulin together account for over 45% of total revenue, supported by their extensive use in food and dietary supplements.
By demography, adults represent nearly 50% of the market share, attributed to their proactive focus on digestive wellness and preventive nutrition habits.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Drivers:

Rising Health Awareness and Focus on Gut Wellness

The Global Prebiotics Market is driven by growing consumer awareness about the link between gut health and overall well-being. People are increasingly recognizing the importance of prebiotics in promoting digestive balance and enhancing immunity. The rising prevalence of gastrointestinal issues and lifestyle-related disorders has strengthened the demand for prebiotic-enriched foods and supplements. It benefits from a shift toward preventive healthcare and self-care solutions supported by nutrition-focused lifestyles across both developed and emerging economies.

For Instance, PepsiCo announced the launch of Pepsi Prebiotic Cola in July 2025, introducing a new product to the traditional cola category featuring 3 grams of prebiotic fiber and 5 grams of cane sugar per 12-ounce serving.

Expanding Use in Functional Foods and Beverages

The increasing incorporation of prebiotics into functional food and beverage formulations supports market growth. Food manufacturers are developing products that combine taste, nutrition, and health benefits, appealing to a wide customer base. Dairy products, infant formulas, and fortified snacks are key categories integrating prebiotic fibers. It gains traction due to consumer demand for convenient and health-oriented food options that support digestion and long-term wellness.

For Instance, Coca-Cola’s Simply brand launched Simply Pop, a new line of prebiotic sodas. Each 12-ounce can contains 6 grams of prebiotic fiber along with vitamin C and zinc.

Growing Demand for Natural and Clean-Label Ingredients

The shift toward clean-label and plant-based products has accelerated the adoption of natural prebiotics sourced from chicory root, bananas, and whole grains. Consumers prefer transparent ingredient lists and avoid artificial additives, supporting market expansion. Manufacturers are focusing on eco-friendly sourcing and processing methods to meet sustainability expectations. It continues to attract health-conscious buyers seeking non-GMO and chemical-free nutritional alternatives.

Technological Advancements and Product Innovation

Ongoing advancements in extraction and formulation technologies are improving the quality and functionality of prebiotic ingredients. Companies are investing in research to develop next-generation prebiotics with enhanced solubility, stability, and synergistic benefits. New product launches targeting specific health functions such as immunity, metabolism, and cognitive support are expanding consumer reach. It demonstrates continuous innovation that drives competitiveness and widens its application across food, pharmaceuticals, and animal nutrition industries.

Market Trends:

Rising Integration of Prebiotics in Functional and Fortified Products

The Global Prebiotics Market is witnessing strong growth through the rising integration of prebiotic fibers in functional and fortified food products. Food manufacturers are launching yogurts, cereals, beverages, and baked goods enriched with inulin and oligosaccharides to meet consumer demand for gut-friendly nutrition. The trend toward preventive healthcare and immunity-boosting foods continues to strengthen global consumption patterns. It benefits from increased awareness of the microbiome’s role in overall wellness and the effectiveness of prebiotics in maintaining digestive balance. Major brands are emphasizing science-backed claims and clean-label transparency to build consumer trust. The expansion of e-commerce platforms and functional food retail channels further supports accessibility and visibility of prebiotic-based products across diverse demographics.

For Instance, ingredient supplier Sensus published an article illustrating how manufacturers could use its chicory root fiber to formulate a no-added-sugar cereal bar with over 5 grams of fiber per 25g serving, boosting the product’s overall fiber content compared to a conventional cereal bar

Innovation in Ingredient Development and Personalized Nutrition Solutions

Rapid advancements in biotechnology and ingredient formulation are transforming the prebiotic landscape. Manufacturers are developing next-generation prebiotics derived from diverse natural sources such as seaweed, pulses, and root vegetables to improve bioavailability and functional benefits. It aligns with the growing trend of personalized nutrition, where consumers seek customized dietary solutions based on gut microbiome analysis. The integration of prebiotics with probiotics, forming synbiotic blends, is gaining momentum in dietary supplements and functional foods. Companies are also investing in clinical research to validate claims and expand regulatory approvals for new applications. Sustainable sourcing, reduced carbon processing, and circular production practices are emerging as key differentiators for competitive positioning in the market.

For Instance, Meiji Food Materia Co., Ltd. supplies its fructooligosaccharide product, Mayoligo®, globally, with total supply recently exceeding 20,000 tonnes annually. As a fructooligosaccharide (FOS), Mayoligo® is a functional ingredient and low-calorie sugar substitute.

Market Challenges Analysis:

High Production Costs and Limited Raw Material Availability

The Global Prebiotics Market faces challenges due to high production costs and dependency on specific raw materials such as chicory root and natural fibers. Extraction and purification processes require advanced technology and quality control, increasing operational expenses for manufacturers. It struggles with fluctuating supply chains and limited agricultural yields that affect raw material pricing and stability. Small and medium producers find it difficult to compete with established brands that can absorb higher input costs. Rising energy prices and global transportation issues further increase production complexity. These factors limit scalability and impact overall profit margins across the value chain.

Regulatory Barriers and Low Consumer Awareness in Emerging Markets

Strict regulatory requirements for health claims and ingredient labeling create hurdles for market entry in several regions. Manufacturers must comply with varying standards across Europe, North America, and Asia-Pacific, increasing time-to-market for new formulations. It encounters additional challenges in developing regions where consumer awareness about prebiotic benefits remains limited. Misunderstanding between probiotics and prebiotics often leads to low adoption rates. Companies must invest heavily in marketing and education to improve brand perception and product acceptance. Regulatory delays and high compliance costs restrict innovation speed and expansion opportunities for many industry participants.

Market Opportunities:

Expanding Demand in Personalized and Preventive Nutrition

The Global Prebiotics Market holds significant opportunities in the growing field of personalized and preventive nutrition. Consumers are seeking tailored health solutions supported by microbiome research and digital health platforms. It benefits from increasing interest in customized diets and supplements designed to improve gut health, immunity, and metabolism. The integration of prebiotics into personalized wellness programs presents new revenue streams for food and nutraceutical companies. Brands focusing on data-driven nutrition and gut microbiome analytics can capture a competitive edge. Partnerships between health-tech companies and ingredient manufacturers are likely to accelerate innovation and accessibility in this segment.

Emerging Applications Across Pharmaceuticals and Animal Nutrition

New opportunities are emerging with the application of prebiotics beyond traditional food and beverage sectors. Pharmaceutical firms are exploring prebiotics for drug delivery enhancement and treatment of metabolic disorders. It also finds rising adoption in animal nutrition for improving gut health, immunity, and growth performance in livestock. Growing concerns about antibiotic resistance are promoting the use of prebiotic feed additives as natural alternatives. Expanding veterinary research and government support for sustainable animal farming strengthen this adoption. These applications diversify the market scope and reduce dependency on food-based demand cycles.

Market Segmentation Analysis:

By Product Segment

The Global Prebiotics Market is segmented by product into fructo-oligosaccharides, inulin, pyrodextrins, galacto-oligosaccharides, soya oligosaccharides, lactulose, isomalto-oligosaccharides, and others. Fructo-oligosaccharides and inulin dominate due to their extensive use in dietary supplements and functional foods. These ingredients support digestive health and immune function, driving demand across developed economies. It gains further traction from rising consumer preference for natural fibers sourced from chicory roots and plants. Product diversification and innovation continue to strengthen the market’s value proposition across food, pharmaceutical, and animal nutrition sectors.

For instance, BENEO invested €30 million in 2022 to expand its Pemuco (Chile) and Oreye (Belgium) chicory root fiber facilities, increasing global inulin production capacity by over 40 percent.

By Disease Type Segment

Prebiotics are increasingly applied in managing conditions such as diabetes, infections, cardiovascular diseases, osteoporosis, inflammatory bowel disease (IBD), and immunomodulation. The segment addressing diabetes and gut-related disorders holds a leading position due to higher consumer awareness and medical endorsements. It benefits from growing research linking gut microbiota to chronic disease prevention. Demand for targeted formulations aimed at improving metabolic and immune health further expands this segment’s growth potential. Rising investments in clinical studies support credibility and global adoption.

For Instance, A real meta-analysis published in the Journal of Translational Medicine in December 2019, which included 33 randomized controlled trials and 1,346 total participants, found that supplementation with inulin-type fructans (like Orafti® inulin from Beneo) was associated with significant reductions in several glycemic indicators, including fasting blood glucose (FBG), in patients with prediabetes and type 2 diabetes.

By Demography Segment

The market is divided by demography into pediatric, adult, and geriatric groups. Adults represent the largest consumer base due to proactive health management and lifestyle-driven wellness trends. The geriatric population also contributes significantly, driven by increasing cases of digestive issues and metabolic diseases. It experiences strong adoption among pediatric consumers through fortified infant formulas and nutritional supplements. The shift toward preventive healthcare across all age groups sustains consistent market expansion.

Segmentations:

By Product Segment

Fructo-Oligosaccharides
Insulin
Pyrodextrins
Galacto-Oligosaccharides
Soya Oligosaccharides
Lactulose
Isomalto-Oligosaccharides
Others

By Disease Type Segment

Diabetes
Infections
Cardiovascular Diseases
Osteoporosis
IBD
Immunomodulation
Others

By Demography Segment

Pediatric
Adult
Geriatric

By Distribution Channel Segment

Hypermarkets/Supermarkets
Pharmacies and Drug Stores
Specialty Stores
Online Sales
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis:

North America

The North America Prebiotics Market size was valued at USD 1,981.80 million in 2018, growing to USD 2,488.12 million in 2024, and is anticipated to reach USD 4,455.32 million by 2032, at a CAGR of 7.49% during the forecast period. The Global Prebiotics Market in this region holds 35% of the total market share, driven by rising consumer interest in digestive health and functional nutrition. The United States dominates regional growth, supported by high product awareness, advanced food processing capabilities, and continuous innovation by leading manufacturers. It benefits from strong demand for dietary supplements, dairy-based prebiotics, and fortified beverages. Expanding e-commerce platforms and product diversification further support market penetration. Canada and Mexico contribute significantly, driven by nutrition-focused lifestyles and government initiatives promoting wellness.

Europe

The Europe Prebiotics Market size was valued at USD 1,339.20 million in 2018, reaching USD 1,631.59 million in 2024, and is projected to attain USD 2,753.07 million by 2032, expanding at a CAGR of 6.44%. Europe accounts for 30% of the Global Prebiotics Market, supported by high consumer preference for functional and clean-label foods. Germany, France, and the UK lead regional production due to advanced food industries and strong regulatory support for prebiotic integration. It benefits from scientific research validating prebiotic benefits and widespread product availability. Rising demand for natural ingredients and aging population trends strengthen product consumption. The focus on preventive healthcare and sustainability ensures consistent long-term growth across major economies.

Asia Pacific

The Asia Pacific Prebiotics Market size was valued at USD 219.97 million in 2018, rising to USD 287.14 million in 2024, and is expected to reach USD 515.93 million by 2032, registering a CAGR of 7.60%. The region holds 25% of the Global Prebiotics Market share, supported by increasing disposable incomes, growing health awareness, and expanding urban populations. Japan, China, India, and Australia are key contributors, with strong demand for functional foods and beverages. It benefits from policy support for nutritional improvement and growing domestic nutraceutical production. Expansion of retail and online distribution networks further boosts consumer accessibility. The growing focus on immunity and child health supports sustained demand across regional markets.

Latin America

The Latin America Prebiotics Market is experiencing healthy growth, holding 6% of the Global Prebiotics Market share. Brazil and Argentina lead adoption, supported by growing awareness of digestive wellness and an expanding middle-class population. It benefits from wider retail access to functional foods and government nutrition initiatives. Increasing investments by multinational players in local manufacturing and partnerships strengthen regional presence. Product innovation tailored to local preferences continues to expand consumer reach. Demand for fortified beverages and supplements is expected to drive stable long-term growth.

Middle East

The Middle East Prebiotics Market accounts for 3% of the Global Prebiotics Market share, driven by rising awareness of dietary health and lifestyle disease prevention. GCC countries, Israel, and Turkey represent major consumption hubs supported by strong retail infrastructure. It benefits from higher disposable incomes and increasing availability of imported health products. Local companies are entering the market through collaborations and plant-based ingredient offerings. Health-conscious consumers and growing interest in functional foods create favorable conditions for expansion. Regional diversification and modern trade channels are enhancing product penetration.

Africa

The Africa Prebiotics Market holds 2% of the Global Prebiotics Market share and is gradually expanding with rising awareness of digestive and immune health. South Africa and Egypt dominate consumption supported by urbanization and expanding modern retail. It faces supply limitations but benefits from ongoing investment by international players and government health initiatives. Increasing affordability and education about functional nutrition are improving product acceptance. Growing middle-income populations and focus on preventive care are expected to enhance future growth. Regional collaborations and affordable product innovations are helping strengthen market reach across developing economies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

Abbott Laboratories
Archer Daniels Midland Company
BASF SE
Beghin Meiji
BENEO GmbH
Biopolis Life Sciences Private Limited
Ciranda, Inc.
Clasado Limited
Cosucra Groupe Warcoing SA
DuPont de Nemours, Inc.
Galam Group
Ingredion Incorporated
Kerry Group
Nestlé S.A.

Competitive Analysis:

The Global Prebiotics Market is highly competitive, with companies focusing on innovation, partnerships, and product diversification to strengthen their market presence. Key players include Abbott Laboratories, Archer Daniels Midland Company, BASF SE, Beghin Meiji, BENEO GmbH, and Biopolis Life Sciences Private Limited. It is shaped by intense competition among global and regional manufacturers emphasizing quality, safety, and sustainable sourcing. Leading firms are expanding their portfolios through advanced inulin, galacto-oligosaccharides, and fructo-oligosaccharides formulations to meet rising demand for clean-label and functional ingredients. Strategic collaborations, mergers, and acquisitions remain central to achieving geographic and technological expansion. Continuous investment in R&D and clinical validation supports brand credibility and regulatory compliance, reinforcing each company’s long-term positioning in the global market.

Recent Developments:

In August 2025, Nestlé entered a partnership with IBM Research to develop sustainable food packaging using generative AI, aiming to reduce plastic use through advanced, data‑driven material science.
In October 2025, Abbott Laboratories announced strong third-quarter 2025 results emphasizing major growth in its Medical Devices and Diabetes Care segments, particularly due to its FreeStyle Libre technology and expanding device portfolio in global markets.

Report Coverage:

The research report offers an in-depth analysis based on Product, Disease Type, Demography, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

Growing consumer focus on gut health and preventive nutrition will continue to drive market expansion.
Product innovation using plant-based and sustainable raw materials will enhance competitiveness.
Integration of prebiotics into functional foods, beverages, and supplements will strengthen retail visibility.
Technological advancements in extraction and formulation processes will improve product quality and cost efficiency.
Rising collaborations between food manufacturers and biotech firms will accelerate new product launches.
Expanding research on gut microbiome interactions will create opportunities for personalized nutrition solutions.
Increased government support for nutritional awareness will encourage wider adoption across developing economies.
Pharmaceutical and animal nutrition applications will diversify revenue streams and reduce dependence on food-based demand.
Digital health platforms and e-commerce growth will enhance global distribution and consumer reach.
Greater investment in clinical studies and regulatory approvals will solidify credibility and ensure sustainable long-term market growth.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : PREBIOTICS MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by product

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Disease Type Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product & Disease Type Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis by Region

6.1.1. Global Prebiotics Market Import Revenue By Region

6.2. Export Analysis by Region

6.2.1. Global Prebiotics Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global Prebiotics Market: Company Market Share

7.2. Global Prebiotics Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : PREBIOTICS MARKET – BY PRODUCT SEGMENT ANALYSIS

8.1. Prebiotics Market Overview by Product Segment

8.1.1. Prebiotics Market Revenue Share By Product

8.2. Fructo-Oligosaccharides

8.3. Insulin

8.4. Pyrodextrins

8.5. Galacto-Oligosaccharides

8.6. Soya Oligosaccharides

8.7. Lactulose

8.8. Isomalto-Oligosaccharides

8.9. Others

CHAPTER NO. 9 : PREBIOTICS MARKET – BY DISEASE TYPE SEGMENT ANALYSIS

9.1. Prebiotics Market Overview by Disease Type Segment

9.1.1. Prebiotics Market Revenue Share By Disease Type

9.2. Diabetes

9.3. Infections

9.4. Cardiovascular Diseases

9.5. Osteoporosis

9.6. IBD

9.7. Immunomodulation

9.8 Others

CHAPTER NO. 10 : PREBIOTICS MARKET – BY DEMOGRAPHY SEGMENT ANALYSIS

10.1. Prebiotics Market Overview by Demography Segment

10.1.1. Prebiotics Market Revenue Share By Demography

10.2. Pediatric

10.3. Adult

10.4. Geriatric

CHAPTER NO. 11 : PREBIOTICS MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS

11.1. Prebiotics Market Overview by Distribution Channel Segment

11.1.1. Prebiotics Market Revenue Share By Distribution Channel

11.2. Hypermarkets/Supermarkets

11.3. Pharmacies and Drug Stores

11.4. Specialty Stores

11.5. Online Sales

11.6. Others

CHAPTER NO. 12 : PREBIOTICS MARKET – REGIONAL ANALYSIS

12.1. Prebiotics Market Overview by Region Segment

12.1.1. Global Prebiotics Market Revenue Share By Region

12.1.2. Regions

12.1.3. Global Prebiotics Market Revenue By Region

12.1.4. Product

12.1.5. Global Prebiotics Market Revenue By Product

12.1.6. Disease Type

12.1.7. Global Prebiotics Market Revenue By Disease Type

12.1.8. Demography

12.1.9. Global Prebiotics Market Revenue By Demography

12.1.10. Distribution Channel

12.1.11. Global Prebiotics Market Revenue By Distribution Channel

CHAPTER NO. 13 : NORTH AMERICA PREBIOTICS MARKET – COUNTRY ANALYSIS

13.1. North America Prebiotics Market Overview by Country Segment

13.1.1. North America Prebiotics Market Revenue Share By Regi

13.2. North America

13.2.1. North America Prebiotics Market Revenue By Country

13.2.2. Product

13.2.3. North America Prebiotics Market Revenue By Product

13.2.4. Disease Type

13.2.5. North America Prebiotics Market Revenue By Disease Type

13.2.6. Demography

13.2.7. North America Prebiotics Market Revenue By Demography

13.2.8. Distribution Channel

13.2.9. North America Prebiotics Market Revenue By Distribution Channel

13.3. U.S.

13.4. Canada

13.5. Mexico

CHAPTER NO. 14 : EUROPE PREBIOTICS MARKET – COUNTRY ANALYSIS

14.1. Europe Prebiotics Market Overview by Country Segment

14.1.1. Europe Prebiotics Market Revenue Share By Region

14.2. Europe

14.2.1. Europe Prebiotics Market Revenue By Country

14.2.2. Product

14.2.3. Europe Prebiotics Market Revenue By Product

14.2.4. Disease Type

14.2.5. Europe Prebiotics Market Revenue By Disease Type

14.2.6. Demography

14.2.7. Europe Prebiotics Market Revenue By Demography

14.2.8. Distribution Channel

14.2.9. Europe Prebiotics Market Revenue By Distribution Channel

14.3. UK

14.4. France

14.5. Germany

14.6. Italy

14.7. Spain

14.8. Russia

14.9. Rest of Europe

CHAPTER NO. 15 : ASIA PACIFIC PREBIOTICS MARKET – COUNTRY ANALYSIS

15.1. Asia Pacific Prebiotics Market Overview by Country Segment

15.1.1. Asia Pacific Prebiotics Market Revenue Share By Region

15.2. Asia Pacific

15.2.1. Asia Pacific Prebiotics Market Revenue By Country

15.2.2. Product

15.2.3. Asia Pacific Prebiotics Market Revenue By Product

15.2.4. Disease Type

15.2.5. Asia Pacific Prebiotics Market Revenue By Industry Vertica

15.2.6. Demography

15.2.7. Asia Pacific Prebiotics Market Revenue By Demography

15.2.8. Distribution Channel

15.2.9. Asia Pacific Prebiotics Market Revenue By Distribution Channel

15.3. China

15.4. Japan

15.5. South Korea

15.6. India

15.7. Australia

15.8. Southeast Asia

15.9. Rest of Asia Pacific

CHAPTER NO. 16 : LATIN AMERICA PREBIOTICS MARKET – COUNTRY ANALYSIS

16.1. Latin America Prebiotics Market Overview by Country Segment

16.1.1. Latin America Prebiotics Market Revenue Share By Region

16.2. Latin America

16.2.1. Latin America Prebiotics Market Revenue By Country

16.2.2. Product

16.2.3. Latin America Prebiotics Market Revenue By Product

16.2.4. Disease Type

16.2.5. Latin America Prebiotics Market Revenue By Disease Type

16.2.6. Demography

16.2.7. Latin America Prebiotics Market Revenue By Demography

16.2.8. Distribution Channel

16.2.9. Latin America Prebiotics Market Revenue By Distribution Channel

16.3. Brazil

16.4. Argentina

16.5. Rest of Latin America

CHAPTER NO. 17 : MIDDLE EAST PREBIOTICS MARKET – COUNTRY ANALYSIS

17.1. Middle East Prebiotics Market Overview by Country Segment

17.1.1. Middle East Prebiotics Market Revenue Share By Region

17.2. Middle East

17.2.1. Middle East Prebiotics Market Revenue By Country

17.2.2. Product

17.2.3. Middle East Prebiotics Market Revenue By Product

17.2.4. Disease Type

17.2.5. Middle East Prebiotics Market Revenue By Disease Type

17.2.6. Demography

17.2.7. Middle East Prebiotics Market Revenue By Demography

17.2.8. Distribution Channel

17.2.9. Middle East Prebiotics Market Revenue By Distribution Channel

17.3. GCC Countries

17.4. Israel

17.5. Turkey

17.6. Rest of Middle East

CHAPTER NO. 18 : AFRICA PREBIOTICS MARKET – COUNTRY ANALYSIS

18.1. Africa Prebiotics Market Overview by Country Segment

18.1.1. Africa Prebiotics Market Revenue Share By Region

18.2. Africa

18.2.1. Africa Prebiotics Market Revenue By Country

18.2.2. Product

18.2.3. Africa Prebiotics Market Revenue By Product

18.2.4. Disease Type

18.2.5. Africa Prebiotics Market Revenue By Disease Type

18.2.6. Demography

18.2.7. Africa Prebiotics Market Revenue By Demography

18.2.8. Distribution Channel

18.2.9. Africa Prebiotics Market Revenue By Distribution Channel

18.3. South Africa

18.4. Egypt

18.5. Rest of Africa

CHAPTER NO. 19 : COMPANY PROFILES

19.1. Abbott Laboratories

19.1.1. Company Overview

19.1.2. Product Portfolio

19.1.3. Financial Overview

19.1.4. Recent Developments

19.1.5. Growth Strategy

19.1.6. SWOT Analysis

19.2. Archer Daniels Midland Company

19.3. BASF SE

19.4. Beghin Meiji

19.5. BENEO GmbH

19.6. Biopolis Life Sciences Private Limited

19.7. ciranda, Inc.

19.8. Clasado Limited

19.9. Cosucra Groupe Warcoing SA

19.10. DuPont de Nemours, Inc.

19.11 Galam Group

19.12. Ingredion Incorporated

19.13. Kerry Group

19.14. Nestlé S.A.

19.15. Parmalat S.p.A.

19.16. Roquette Frères

19.17. Sensus B.V.

19.18. Tereos Group

19.19. The Kraft Heinz Company

19.20. Yakult Honsha Co. Ltd.

Request A Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions

What is the current size of the prebiotics market?

The Global Prebiotics Market was valued at USD 6,861.99 million in 2024 and is projected to reach USD 12,304.06 million by 2032, driven by strong demand for functional and clean-label nutritional products worldwide.

At what Compound Annual Growth Rate is the Global Prebiotics Market projected to grow between 2024 and 2032?

The Global Prebiotics Market is expected to expand at a CAGR of 7.65% during the forecast period, supported by rising awareness of gut health and preventive nutrition trends.

What factors are driving the growth of the prebiotics market?

Key factors driving the growth of the prebiotics market include increasing awareness of gut health, rising consumer demand for functional foods and dietary supplements, and the growing prevalence of digestive disorders. Additionally, technological advancements in prebiotic production are expanding the range of available ingredients.

What are some challenges faced by the prebiotics market?

Challenges in the prebiotics market include a lack of awareness regarding the health benefits of prebiotics among consumers and regulatory hurdles that can impact product development and marketing.

Who are the major players in the prebiotics market?

Major players in the prebiotics market include BENEO, Cargill, Yakult Honsha, FrieslandCampina, and Danone, among others, who are actively involved in research and innovation to meet evolving consumer demands.

Which segment is leading the market share?

The food and beverages segment lead the market share, driven by increasing consumer interest in health-promoting products that incorporate prebiotic ingredients for enhanced digestive health.

About Author

Rajdeep Kumar Deb

Lead Analyst – Consumer & Finance

Rajdeep brings a decade of consumer goods and financial services insight to strategic market analysis.

View Profile

Related Reports

Dairy Alternatives Market

Dairy Alternatives Market size was valued at USD 19,166.7 million in 2018 and is expected to reach USD 29,684.3 million in 2024, growing further to USD 62,028.0 million by 2032, at a CAGR of 9.70% during the forecast period.

Food Coating Ingredients Market

Food Coating Ingredients Market size was valued USD 3.49 billion in 2024 and is anticipated to reach USD 6.12 billion by 2032, at a CAGR of 7.3% during the forecast period.

Food Binders Market

The Food Binders Market was valued at USD 4.03 billion in 2024 and is projected to reach USD 5.67 billion by 2032, growing at a CAGR of 4.38% during the forecast period.

Food and Beverage Sterilizing Agent Market

The Food and Beverage Sterilizing Agent Market was valued at USD 3.68 billion in 2024 and is projected to reach USD 4.45 billion by 2032, expanding at a CAGR of 2.4% during the forecast period.

Omega 3 Market

Omega 3 Market size was valued at USD 3,965.4 Million in 2018 and reached USD 6,901.1 Million in 2024. It is anticipated to grow to USD 15,043.1 Million by 2032, at a CAGR of 10.31% during the forecast period.

Australia Prebiotic Market

The Australia Prebiotic Market size was valued at USD 56.30 million in 2018 to USD 74.31 million in 2024 and is anticipated to reach USD 139.57 million by 2032, at a CAGR of 8.20% during the forecast period.

Pet Food Market

The Global Pet Food Market size was valued at USD 94,832.8 million in 2018 to USD 1,27,582.8 million in 2024 and is anticipated to reach USD 1,98,034.1 million by 2032, at a CAGR of 5.70% during the forecast period.

Food Processor Market

The Food Processor market size was valued at USD 1.99 billion in 2024 and is projected to reach USD 2.98 billion by 2032, growing at a CAGR of 5.2% during the forecast period.

UK Probiotic Market

The UK Probiotic Market size was valued at USD 2,039.45 million in 2018 to USD 3,141.38 million in 2024 and is anticipated to reach USD 8,849.18 million by 2032, at a CAGR of 13.82% during the forecast period.

Italy Probiotic Market

The Italy Probiotic Market size was valued at USD 1,078.44 million in 2018 to USD 1,640.65 million in 2024 and is anticipated to reach USD 4,082 million by 2032, at a CAGR of 12.07% during the forecast period.

Probiotics Market

The Global Probiotic Market size was valued at USD 62.3 billion in 2018 to USD 99.29 billion in 2024 and is anticipated to reach USD 280.37 billion by 2032, at a CAGR of 13.92% during the forecast period.

Japan Probiotics Market

The Japan Probiotic Market size was valued at USD 2,704.82 million in 2018 to USD 4,428.37 million in 2024 and is anticipated to reach USD 12,601.90 million by 2032, at a CAGR of 13.97%during the forecast period.

Licence Option

Single User

$4999

Multi User

$6999

Enterprise

$12999

Report delivery within 24 to 48 hours

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Request A Free Sample

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample